Showing all 2 results

Show sidebar

DEXA 40 – EQUI SYSTEM 50 ML

$35.00
Excelent dexa 0.4% for race: Injectable corticoid formulation based on Dexamethasone 21 phosphate  40 mg. COMPOSITION Dexamethasone 21 phosphate: 40 mg. Excipients q.s.: 10 ml. ACTION Antinflammatory. Corticoid. INDICATIONS Acute and chronic inflammatory conditions of the locomotor system (myositis, tendonitis, synovitis, osteitis, osteoarthritis). Shock. Allergy. Inflammatory or edematous conditions of the airways. Hemoglobinuria. Photosensitization. Neonatal maladjustment syndrome. CONTRAINDICATIONS Don´t use: in case of suspected digestive ulcers or in the presence of systemic mycoses. in lung infections or in intralesional form in localized infections if the corresponding antibiotic coverage is lacking. Don´t administer in parallel to any vaccine, or in the presence of osteoporosis. Don´t use in pregnant in the last third of gestation. Since it is a fast-acting drug, its use should not be extended for more than 7 days. Since the product will be used in circumstances beyond the control of the processor, the manufacturer is not responsible for the consequences arising from the inappropriate use of the same. SIDE EFFECTS AND ADVERSE REACTIONS Over-administered for long periods, corticosteroids can cause sodium and fluid retention, potassium loss, muscle weakness, osteoporosis, and delayed healing. DOSAGE It can be given intramuscularly, intravenously or intraarticularly. Adult horses 10 to 40 mg per day. Dosification & Administration for Race : For professional application not detected, read the article about dexa for race:
For safe application not detected pre-race: 5 ml for 5 days, suspend 2 days before the race

Opticortenol-s

$35.00
Composition Dexamethasone 2.5 mg/ml and prednisolone 7.5 mg/ml Indications To implement a general or local glucocorticoterapia because it promotes gluconeogenesis and induces an anti-inflammatory, anti-allergic and anti-toxic effects. The main indications are: arthritis, synovitis, inflammation of the tendon sheaths, strains, itching, eczema, dermatitis, as an adjuvant in infectious diseases. Dosage and administration From 0.016 to 0.025 ml/kg of body weight (1.6 to 2.5 ml/100 kg bodyweight) of 0.04 mg of dexamethasone trimeltilacetato and 0.12 mg of prednisolone - 0.0625 and 0.1875 mg of dexamethasone trimetilacetato mg prednisolone / kg body weight. Local treatment: from 1 to 3 ml (where 1 ml corresponds to 0.005 mg / kg body weight of Dexamethasone trimetilacetato and 0,015 mg / kg bodyweight of prednisolone).